|
| | Issue Date | Title | Contributor(s) | Type | Cat. |
| 1 | 2023 | Trial Design for Cancer Immunotherapy: A Methodological Toolkit | Saad, Everardo D.; Coart, Elisabeth; DELTUVAITE-THOMAS, Vaiva; GARCIA BARRADO, Leandro; BURZYKOWSKI, Tomasz; BUYSE, Marc | Journal Contribution | A1 |
| 2 | 2023 | Minimization in randomized clinical trials | Coart, Elisabeth; Bamps, Perrine; Quinaux, Emmanuel; Sturbois, Geneviève; Saad, Everardo D; BURZYKOWSKI, Tomasz; BUYSE, Marc | Journal Contribution | A1 |
| 3 | 2023 | Generalized pairwise comparisons for censored data: An overview | DELTUVAITE-THOMAS, Vaiva; VERBEECK, Johan; BURZYKOWSKI, Tomasz; BUYSE, Marc; Tournigand, Christophe; MOLENBERGHS, Geert; THAS, Olivier | Journal Contribution | A1 |
| 4 | 2022 | Clinical Trial Endpoints in Metastatic Cancer: Using Individual Participant Data to Inform Future Trials Methodology | Goldberg, Richard M.; Adams, Richard; BUYSE, Marc; Eng, Cathy; Grothey, Axel; Andre, Thierry; Sobrero, Alberto F.; Lichtman, Stuart M.; Benson, Al B.; Punt, Cornelis J. A.; Maughan, Tim; BURZYKOWSKI, Tomasz; Sommeijer, Dirkje; Saad, Everardo D.; Shi, Qian; Coart, Elisabeth; Chibaudel, Benoist; Koopman, Miriam; Schmoll, Hans-Joachim; Yoshino, Takayuki; Taieb, Julien; Tebbutt, Niall C.; Zalcberg, John; Tabernero, Josep; Van Cutsem , Eric; Matheson, Alastair; de Gramont, Aimery | Journal Contribution | A1 |
| 5 | 2022 | Surrogacy Beyond Prognosis: The Importance of “Trial-Level” Surrogacy | BUYSE, Marc; Saad, Everardo D.; BURZYKOWSKI, Tomasz; Regan, Meredith M.; Sweeney, Christopher S. | Journal Contribution | A1 |
| 6 | 2022 | The case against censoring of progression-free survival in cancer clinical trials - A pandemic shutdown as an illustration | Jamoul, Corinne; Collette, Laurence; Coart, Elisabeth; D'Hollander, Koenraad; BURZYKOWSKI, Tomasz; Saad, Everardo D; BUYSE, Marc | Journal Contribution | A1 |
| 7 | 2022 | Using an interim analysis based exclusively on an early outcome in a randomized clinical trial with a long-term clinical endpoint | Barrado, Leandro Garcia; BURZYKOWSKI, Tomasz; LEGRAND, Catherine; BUYSE, Marc | Journal Contribution | A1 |
| 8 | 2021 | Evaluation of surrogate endpoints | MOLENBERGHS, Geert; SHKEDY, Ziv; BURZYKOWSKI, Tomasz; BUYSE, Marc; ALONSO ABAD, Ariel; VAN DER ELST, Wim | Book Section | B2 |
| 9 | 2020 | Unbiasedness and efficiency of non-parametric and UMVUE estimators of the probabilistic index and related statistics | VERBEECK, Johan; DELTUVAITE-THOMAS, Vaiva; BERCKMOES, Ben; BURZYKOWSKI, Tomasz; AERTS, Marc; THAS, Olivier; BUYSE, Marc; MOLENBERGHS, Geert | Journal Contribution | A1 |
| 10 | 2020 | Progression-free survival (PFS) as a surrogate endpoint for overall survival (OS) in advanced/recurrent gastric cancer (AGC) treatment: Individual-patient-data (IPD) based meta-analysis of randomized trials | Oba, Koji; Paoletto, Xavier; Bang, Yung-Jue; Bouche, Olivier; Ducreux, Michel; Michiels, Stefan; Moehler, MarkusH; Morita, Satoshi; Ohashi, Yasuo; Sakamoto, Junichi; Sasako, Mitsuru; Shitara, Kohei; Van Cutsem, Eric; BUYSE, Marc; BURZYKOWSKI, Tomasz | Journal Contribution | M |
| 11 | 2020 | Meta-analytic approach to evaluation of surrogate endpoints | BURZYKOWSKI, Tomasz; BUYSE, Marc; MOLENBERGHS, Geert; ALONSO ABAD, Ariel; VAN DER ELST, Wim; SHKEDY, Ziv | Book Section | B2 |
| 12 | 2019 | Disease-free survival as a surrogate for overall survival in patients with HER2-positive, early breast cancer in trials of adjuvant trastuzumab for up to 1 year: a systematic review and meta-analysis | Saad, Everardo D.; Squifflet, Pierre; BURZYKOWSKI, Tomasz; Quinaux, Emmanuel; Delaloge, Suzette; Mavroudis, Dimitris; Perez, Edith; Piccart-Gebhart, Martine; Schneider, Bryan P.; Slamon, Dennis; Wolmark, Norman; BUYSE, Marc | Journal Contribution | A1 |
| 13 | 2019 | Detection of atypical data in multicenter clinical trials using unsupervised statistical monitoring | Trotta, Laura; Kabeya, Yuusuke; BUYSE, Marc; Doffagne, Erik; Venet, David; Desmet, Lieven; BURZYKOWSKI, Tomasz; Tsuburaya, Akira; Yoshida, Kazuhiro; Miyashita, Yumi; Morita, Satoshi; Sakamoto, Junichi; Praveen, Paurush; Oba, Koji | Journal Contribution | A1 |
| 14 | 2019 | A Poisson approach to the validation of failure time surrogate endpoints in individual patient data meta-analyses | Rotolo, Federico; PAOLETTI, Xavier; BURZYKOWSKI, Tomasz; BUYSE, Marc; Michiels, Stefan | Journal Contribution | A1 |
| 15 | 2019 | Evaluation of Continuous Tumor-Size-Based End Points as Surrogates for Overall Survival in Randomized Clinical Trials in Metastatic Colorectal Cancer | BURZYKOWSKI, Tomasz; Coart, E.; Saad, E.D.; Shi, Q.; Sommeijer, D.W.; Bokemeyer, C.; Díaz-Rubio, E.; Douillard, Jean-Yves; Falcone, A.; Fuchs, C.; Goldberg, R.M.; Hecht, R.; Hoff, P.M.; Hurwitz, H.; Kabbinavar, F.F.; Koopman, M.; Maughan, T.; Punt, C.J.A.; Saltz, L.; Schmoll, Hans-Joachim; Seymour, M.T.; Tebbutt, N.C.; Tournigand, C.; Van Cutsem, E.; de Gramont, A.; Zalcberg, J.R.; BUYSE, Marc | Journal Contribution | A1 |
| 16 | 2019 | Chronological Trends in Progression-Free, Overall, and Post-Progression Survival in First-Line Therapy for Advanced NSCLC | Rutkowski, Jacek; Saad, Everardo D.; BURZYKOWSKI, Tomasz; BUYSE, Marc; Jassem, Jacek | Journal Contribution | A1 |
| 17 | 2018 | The search for surrogate endpoints for immunotherapy trials | BUYSE, Marc; BURZYKOWSKI, Tomasz; Saad, Everardo D. | Journal Contribution | A2 |
| 18 | 2018 | Understanding and Communicating Measures of Treatment Effect on Survival: Can We Do Better? | Saad, Everardo D.; Zalcberg, John R.; Peron, Julien; Coart, Elisabeth; BURZYKOWSKI, Tomasz; BUYSE, Marc | Journal Contribution | A1 |
| 19 | 2018 | Statistical evaluation of surrogate endpoints in cancer clinical trials | BUYSE, Marc; MOLENBERGHS, Geert; PAOLETTI, Xavier; Oba, K.; ALONSO ABAD, Ariel; VAN DER ELST, Wim; BURZYKOWSKI, Tomasz | Book Section | B2 |
| 20 | 2017 | Applied Surrogate Endpoint Evaluation Methods with SAS and R | ALONSO ABAD, Ariel; BIGIRUMURAME, Theophile; BURZYKOWSKI, Tomasz; BUYSE, Marc; MOLENBERGHS, Geert; MUCHENE, Leacky; PERUALILA, Nolen Joy; SHKEDY, Ziv; VAN DER ELST, Wim | Book | B1 |
Loading...
5
0
5
0
false